Helicon Therapeutics is categorized under Commercial Medical Research in San Diego, CA and active since 1997.
Helicon Therapeutics was established in 1997, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 6213400 by the NAICS.
If you are seeking more information, feel free to contact Ken Johns, Chief Executive Officer at the company’s single location by writing to 7473 Lusk Boulevard, San Diego, California CA 92121 or by phoning (858) 246-8100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Helicon Therapeutics |
| Contact Person: | Ken Johns, Chief Executive Officer |
| Address: | 7473 Lusk Boulevard, San Diego, California 92121 |
| Phone Number: | (858) 246-8100 |
| Website Address: | helicontherapeutics.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 6213400 |
| Share This Business: |
Helicon Therapeutics was started in 1997 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 6213400. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Ken Johns, Chief Executive Officer for inquiries that concern Helicon Therapeutics by calling the company number (858) 246-8100, as your correspondence is most welcome. Additionally, the physical location of the single location of Helicon Therapeutics can be found at the coordinates 32.9001,-117.21627 as well as the street address 7473 Lusk Boulevard in San Diego, California 92121.
For its online presence, you may visit Helicon Therapeutics’s website at helicontherapeutics.com and engage with its social media outlets through on Twitter and on Facebook.